SCHEMBL5384654

SCHEMBL5384654

COc1ccc2nc(-c3ccc(S(=O)(=O)c4ccccc4)cc3)oc(=O)c2c1

nearest known ligand 0.64

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 7/20 0.64
▸ MAPT P10636 6/20 0.64
▸ KDM4E B2RXH2 5/20 0.64
▸ NPC1 O15118 4/20 0.64
▸ SMN1; SMN2 Q16637 3/20 0.64
▸ RAB9A P51151 3/20 0.64
▸ LMNA P02545 2/20 0.64
▸ C1R P00736 2/20 0.60
▸ HPGD P15428 5/20 0.57
▸ F2 P00734 1/20 0.57
▸ KMT2A Q03164 1/20 0.57
▸ HSD17B10 Q99714 2/20 0.56
▸ TP53 P04637 4/20 0.53
▸ GAA P10253 3/20 0.50
▸ GLA P06280 1/20 0.50
▸ PKM P14618 1/20 0.50
▸ USP2 O75604 1/20 0.49
▸ PTPN2 P17706 2/20 0.48
▸ PTPN1 P18031 2/20 0.48
▸ PTPN5 P54829 2/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5376370 0.88 NPC1 (0.73) ALDH1A1MAPTKDM4ENPC1SMN1; SMN2
SCHEMBL2537004 0.88 MAPT (0.72) ALDH1A1MAPTKDM4ENPC1SMN1; SMN2
SCHEMBL6563993 0.82 MAPT (0.65) ALDH1A1MAPTKDM4ENPC1SMN1; SMN2
SCHEMBL5381075 0.82 TP53 (0.65) ALDH1A1MAPTKDM4ENPC1SMN1; SMN2
SCHEMBL693362 0.81 ELANE (0.62) ALDH1A1MAPTKDM4ENPC1SMN1; SMN2
SCHEMBL5376982 0.80 RAB9A (0.46) ALDH1A1MAPTKDM4ENPC1SMN1; SMN2
SCHEMBL1463884 0.79 ALDH1A1 (0.75) ALDH1A1MAPTKDM4ENPC1SMN1; SMN2
SCHEMBL5371556 0.79 ALDH1A1 (0.60) ALDH1A1MAPTKDM4ENPC1SMN1; SMN2
SCHEMBL11104577 0.79 POLB (0.61) ALDH1A1MAPTKDM4ENPC1SMN1; SMN2
SCHEMBL692625 0.79 ALDH1A1 (1.00) ALDH1A1MAPTKDM4ENPC1SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7244776-B2 Ultraviolet light absorbers CIBA SPECIALTY CHEMICALS CORPORATION (US) 2007-07-17 — — US disclosed
US-20070100031-A1 Ultraviolet light absorbers RAVICHANDRAN RAMANATHAN 2007-05-03 — — US disclosed
US-7173128-B2 Ultraviolet light absorbers CIBA SPECIALTY CHEMICALS CORPORATION (US) 2007-02-06 — — US disclosed
US-20040192684-A1 Ultraviolet light absorbers CIBA SPECIALTY CHEMICALS CORPORATION 2004-09-30 — — US disclosed
EP-1430038-A1 ULTRAVIOLET LIGHT ABSORBERS Ciba SC Holding AG (CH) 2004-06-23 — — EP disclosed
WO-2003016292-A1 ULTRAVIOLET LIGHT ABSORBERS CIBA SPECIALTY CHEMICALS HOLDING INC. (CH) 2003-02-27 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040192684-A1 Ultraviolet light absorbers UNG, MSH6, MAL2 ALDH1A1 131/4885MAPT 904/4885KDM4E 442/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback